Chemical probes are urgently needed to functionally annotate hitherto-untargeted kinases and stimulate new drug discovery efforts to address unmet medical needs. The size of the human kinome combined with the high cost associated with probe generation severely limits access to new probes. We propose a large-scale public-private partnership as a new approach that offers economies of scale, minimized redundancy and sharing of risk and cost.
This is a preview of subscription content
Subscribe to Journal
Get full journal access for 1 year
only $9.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Fedorov, O., Muller, S. & Knapp, S. Nat. Chem. Biol. 6, 166–169 (2010).
Edwards, A.M. et al. Nature 470, 163–165 (2011).
Bantscheff, M. et al. Nat. Biotechnol. 25, 1035–1044 (2007).
Patricelli, M.P. et al. Chem. Biol. 18, 699–710 (2011).
Davis, M.I. et al. Nat. Biotechnol. 29, 1046–1051 (2011).
Lin, X. et al. J. Med. Chem. 55, 5749–5759 (2012).
Fedorov, O. et al. Proc. Natl. Acad. Sci. USA 104, 20523–20528 (2007).
Frye, S.V. Nat. Chem. Biol. 6, 159–161 (2010).
Workman, P. & Collins, I. Chem. Biol. 17, 561–577 (2010).
Weigelt, J. EMBO Rep. 10, 941–945 (2009).
Cohen, P. Biochem. J. 425, 53–54 (2010).
Dowling, J.E. et al. ACS Med. Chem. Lett. 3, 278–283 (2012).
Al-Lazikani, B., Banerji, U. & Workman, P. Nat. Biotechnol. 30, 679–692 (2012).
Di Paolo, J.A. et al. Nat. Chem. Biol. 7, 41–50 (2011).
Deng, X. et al. Nat. Chem. Biol. 7, 203–205 (2011).
Medina, J.R. et al. J. Med. Chem. 54, 1871–1895 (2011).
Zhang, T. et al. Chem. Biol. 19, 140–154 (2012).
Zhang, J. et al. Natur. 463, 501–506 (2010).
Fedorov, O. et al. Chem. Biol. 18, 67–76 (2011).
Mott, B.T. et al. Bioorg. Med. Chem. Lett. 19, 6700–6705 (2009).
Shimomura, T. et al. Mol. Cancer Ther. 9, 157–166 (2010).
Koeberle, S.C. et al. Nat. Chem. Biol. 8, 141–143 (2011).
Bergamini, G. et al. Nat. Chem. Biol. 8, 576–582 (2012); corrigendum 8, 737 (2012).
Golding, S.E. et al. Mol. Cancer Ther. 8, 2894–2902 (2009).
S.K. and A.E. are in the Structural Genomics Consortium, an organization that is funded in part to generate research tools and place them in the public domain without restriction on use. J.B. and P.W. are employees of the Institute of Cancer Research, which has a commercial interest in inhibitors of several kinases. P.W. has relevant commercial interactions with Piramed Pharma, Genentech, Chroma Therapeutics, Sareum, Cyclacel, Astex Pharmaceuticals and AstraZeneca.
About this article
Cite this article
Knapp, S., Arruda, P., Blagg, J. et al. A public-private partnership to unlock the untargeted kinome. Nat Chem Biol 9, 3–6 (2013). https://doi.org/10.1038/nchembio.1113
Nature Methods (2022)
Science China Life Sciences (2022)
Improving the Prediction of Potential Kinase Inhibitors with Feature Learning on Multisource Knowledge
Interdisciplinary Sciences: Computational Life Sciences (2022)
KinOrtho: a method for mapping human kinase orthologs across the tree of life and illuminating understudied kinases
BMC Bioinformatics (2021)
Nature Communications (2021)